TSHATaysha Gene Therapies, Inc.vs its industry peers
A metric-by-metric comparison of Taysha Gene Therapies, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TSHAEsta | $1.3B#8 | — | 3.5x#6 | 137.0x#8 | 17.3%#7 | -22.1%#8 | -1130.6%#8 | -28.1%#5 | — | — | -16.3%#3 | — |
| RXRX | $2.2B#1 | — | 2.4x#4 | 28.9x#7 | 26.9%#6 | -39.1%#11 | -867.9%#7 | -70.5%#9 | -175.2%#3 | — | — | — |
| VCEL | $2.1B#2 | 83.8x#3 | 5.6x#10 | 7.5x#3 | 16.5%#8 | 59.4%#2 | 4.0%#2 | 4.5%#1 | 4.0%#1 | 7#1 | — | — |
| COAG | $1.9B#3 | — | 4.3x#8 | — | — | — | — | 0.0%#2 | — | — | — | — |
| VIR | $1.9B#4 | — | 1.9x#2 | 27.9x#6 | -7.6%#9 | 16.1%#5 | -699.2%#6 | -44.6%#7 | — | — | 90.9%#1 | — |
| MAZE | $1.7B#5 | — | 3.9x#7 | 10.4x#4 | — | -351.0%#13 | -85.3%#4 | -28.9%#6 | -49.4%#2 | — | — | — |
| REPL | $1.7B#6 | — | 8.1x#11 | — | — | -26.9%#9 | — | -153.3%#10 | — | — | — | — |
| NVAX | $1.7B#7 | — | — | 1.5x#1 | 64.7%#3 | 334.8%#1 | 40.3%#1 | — | — | — | — | — |
| VOR | $1.2B#9 | 0.1x#1 | — | — | — | -495.3%#14 | — | — | — | — | — | — |
| INBX | $1.1B#10 | — | — | 812.2x#10 | 550.0%#1 | -108.3%#12 | -10386.5%#10 | — | — | — | -8.7%#2 | — |
| CGEM | $968M#11 | — | 2.4x#5 | — | -100.0%#10 | -31.2%#10 | — | -53.8%#8 | — | — | — | — |
| ODTX | $936M#12 | — | 2.2x#3 | — | — | — | — | 0.0%#2 | — | — | — | — |
| GLUE | $916M#13 | — | 1.9x#1 | 7.4x#2 | 63.5%#4 | 46.9%#3 | -43.8%#3 | -7.9%#4 | — | — | -17.4%#4 | — |
| MGTX | $911M#14 | 10.9x#2 | — | 11.2x#5 | 144.6%#2 | 22.7%#4 | -130.2%#5 | — | — | — | — | — |
| PRME | $855M#15 | — | 21.5x#12 | 184.6x#9 | 55.3%#5 | -2.7%#7 | -4498.1%#9 | -505.3%#12 | — | — | — | — |
| SANA | $766M#16 | — | 5.0x#9 | — | — | 8.5%#6 | — | -158.0%#11 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice